Generating pancreatic cells, identifying Cas9 targets, and more.

Harvard Medical School researchers overcome retroviral concern that was "a showstopper" in early organ transplant research.

New startup, licensing Harvard technology, seeks to bring unprecedented resolution and multiplexing power to standard microscopes at very low cost, aiming to transform biomedical discovery and digital pathology.

Accelerator supports Harvard faculty in conducting and developing applied life science research.